Programmed Cell Death Protein 1 Inhibitor-Mediated Peripheral Neuropathy

Programmed Cell Death Protein 1 Inhibitor-Mediated Peripheral Neuropathy

The discovery of immune checkpoint inhibitors (ICIs) has revolutionized the model of antitumor therapy. With the continuous deepening of the research on the mechanism of immunotherapy, ICIs, such as programmed cell death protein 1 (PD-1), programmed death-ligand 1 inhibitors and cytotoxic T lymphocy...

Full description

Bibliographic Details
Main Authors: Yanyun Ao, BA, Ming Gao, MM, Binbin Sun, MD, Hongjun Hao, PhD, Huan Yan, MM, Chuntong Li, MD, Decong Sun, MD, Xuejiao Yang, BA, Yanfang Ju, MD, Xia Zhang, MD, Junxun Ma, MD
Format: Article
Language:English
Published: Elsevier 2023-04-01
Series:JTO Clinical and Research Reports
Subjects:
PD-1
Immunotherapy
Neurotoxicity
Peripheral neuropathy
Online Access:http://www.sciencedirect.com/science/article/pii/S2666364323000346

Similar Items

Similar Items